Navigation Links
Cmed Technology to Host Roundtable, Give Presentation About EDC Pain Points at Summit for Clinical Ops Executives (SCOPE)
Date:2/7/2011

NEW PROVIDENCE, N.J., Feb. 7, 2011 /PRNewswire/ -- Cmed Technology, an eClinical technology provider, announced today it will host a roundtable and give a presentation about electronic data capture (EDC) pain points this week at the Summit for Clinical Ops Executives (SCOPE) conference at Florida's Westin Colonnade Coral Gables hotel.

(Logo: http://photos.prnewswire.com/prnh/20100707/NY31446LOGO)

As part of SCOPE's two-day "Electronic Data In Clinical Trials" session, today's interactive roundtable discussion, "What Pain Points Are You Experiencing With EDC Systems?", at 4:30 p.m. highlights some of the issues and frustrations that sponsors and investigator sites are experiencing with today's EDC systems. Cmed Technology also will present "Sites+EDC Does Not Have To=Pain: Building eClinical Platforms for Real-World Scenarios" tomorrow at 9:30 a.m. This stand-alone presentation focuses on the need for eClinical providers to re-examine their approach to EDC systems in order to create an optimal experience.

Throughout the conference, Cmed Technology also will conduct live demonstrations at its Booth 12 of Timaeus 5, a unified on-demand eClinical platform, using notebook PCs and the Apple iPad®. Available now to customers, Timaeus 5, which manages clinical data from Study Design through Reporting, was previewed in October 2010.

What:

Roundtable Discussion: "What Pain Points Are You Experiencing With EDC Systems?"

Stand-alone presentation: "Sites+EDC Does Not Have To=Pain: Building eClinical Platforms for Real-World Scenarios"

Where:

Summit for Clinical Ops Executives (SCOPE) conference, Florida's Westin Colonnade Coral Gables

When:

Roundtable discussion, today (February 7), 4:30 p.m.

Stand-alone presentation, tomorrow (February 8), 9:30 a.m.

"Because the Summit for Clinical Ops Executives caters to a select group of executives, directors and managers, SCOPE engages with vendors like Cmed Technology that are not only experts in the their field like EDC but also innovators in the eClinical industry," said Micah Lieberman, Executive Director of Conferences for the BioPharma Strategy Series, of the Cambridge Healthtech Institute (CHI) that oversees SCOPE. "As a result, our 450 delegates will be walking away from the seminars with clear answers and a more definitive direction to overcome their EDC problems."

About Cmed TechnologyCmed Technology, an eClinical technology provider, offers a unified platform for electronic trial design, paper and electronic data capture, monitoring, coding, data management and reporting. Its Timaeus eClinical platform has been built to respond on-demand to the needs of investigators, data managers and study teams. Timaeus' unique architecture uses advanced distributed cloud computing and mobile technologies to provide the freedom to manage any type of data, for any protocol, anywhere. Timaeus has been used in every phase of clinical research — including early phase, pivotal and late phase studies as well as in globally established and emerging markets. A privately held subsidiary of Cmed Group Ltd. since 2002 with roots from the University of Oxford, Cmed Technology has offices in the United Kingdom, United States and Romania. To learn how Cmed Technology is advancing eClinical trials in an on-demand world, visit http://www.cmedtechnology.com.Media Contact:Christopher Learycleary@cmedtechnology.com or +1 908-795-2006
'/>"/>

SOURCE Cmed Technology
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
2. CardioWest™ Artificial Heart Approved For Highest Reimbursement in CMS History : Plus Up To $53,000 New Technology Add-on Payments
3. Yongye Biotechnology International Retains CCG Investor Relations
4. William F. Prendergast Named One of the Top IP Lawyers in Nanotechnology
5. John Grisham Joins Focused Ultrasound Surgery Foundation Board, Citing Novel Technologys Potential to Help Millions of Patients
6. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
7. [video] Jacques Tizabi, CEO of Universal Detection Technology Discusses Latest Purchase Order on WallSt.nets 3-Minute Press Show
8. Yongye Biotechnology International Announces Second Quarter Results
9. BeaconEquity.com Issues Trade Alerts on Biotechnology Stocks: ELN, PFE, AMGN, DNA, BIIB, GILD
10. ArunA Biomedical Announces Exclusive Worldwide Technology Licensing Agreement to Commercialize Human Embryonic Stem Cell Derived Mesenchymal Cells
11. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for Cancer Therapy Based on Targeting a Biomarker by Novel Investigational Agents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... March 24, 2017 On Thursday, ... session at 5,817.69, down 0.07%; the Dow Jones Industrial ... the S&P 500 closed at 2,345.96, marginally dropping 0.11%. ... closed in green, 4 sectors finished in red, and ... Stock-Callers.com has initiated reports coverage on the following Biotechnology ...
(Date:3/24/2017)... 24, 2017 Agenus Inc. (NASDAQ: AGEN), an ... and cancer vaccines, today announced participation at the following ... William Blair and Maidstone Life Sciences conference "Cancer Immunotherapy ... New York, NY . Agenus will ... at 9:40 am: Robert B. Stein , M.D., ...
(Date:3/23/2017)... ... ... Lajollacooks4u is proud to announce it has become the premiere team-building cooking event company in ... the world, such as Illumina, HP and Qualcomm, and is ranked #1 in its category ... due to its new team building format, a way for teams to not only interact ...
(Date:3/23/2017)... 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) (NW ... therapies for solid tumor cancers, today announced that ... it announced last Friday, March 17, 2017. ... investors securities totaling 28,843,692 shares, comprised of 18,843,692 ... shares of Class C Warrants pre-funded at the ...
Breaking Biology Technology:
(Date:3/2/2017)... , March 2, 2017 Australian stem cell ... (ASX: CYP), has signed an agreement with the Monash ... Monash Biomedicine Discovery Institute and Department of Pharmacology at ... a further preclinical study to support the use of ... asthma.  Asthma is a chronic, long ...
(Date:2/27/2017)...   Strategic Cyber Ventures , the industry,s first ... $3.5 million investment in  Polarity , the first commercial ... DC based and is led by cybersecurity veterans ... Ron Gula , also a longtime cybersecurity veteran and ... series A round of funding. This new funding will ...
(Date:2/21/2017)... -- Der weltweite Biobanking-Sektor wird bis zum ... mit mehr als 50 Vertretern aus verschiedenen Branchen wurde aber ... diese Prognose zu realisieren. ... Zu den Schwierigkeiten für ... für die Biobank, die Implementierung Zeit sparender Technologien, ein ...
Breaking Biology News(10 mins):